Patrick Y. Lu
21Patents
5h-index
37Co-inventors
69Inventor score
Filing activity: Apr 1, 2004 → Feb 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10195368B2 | Handheld high frequency ultrasonic nebulizer for whole respiratory tract drug delivery | Human Necessities | 44 | Active |
| US11058779B2 | Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection | Chemistry; Metallurgy | 15 | Active |
| US8541568B2 | Compositions and methods using siRNA molecules for treatment of gliomas | Chemistry; Metallurgy | 10 | Active |
| US7534878B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 10 | Active |
| US7786092B2 | Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 5 | Active |
| US7893244B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Human Necessities | 5 | Active |
| US7723316B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 4 | Active |
| US9012622B2 | Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer | Chemistry; Metallurgy | 3 | Active |
| US9642873B2 | Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application | Chemistry; Metallurgy | 3 | Active |
| US7893243B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 2 | Active |
| US12006500B2 | Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) | Chemistry; Metallurgy | 1 | Active |
| US12029786B2 | Composition and method of mRNA vaccines against novel coronavirus infection | Chemistry; Metallurgy | 1 | Active |
| US8735567B2 | Multi-targeted RNAi therapeutics for scarless wound healing of skin | Chemistry; Metallurgy | 1 | Active |
| USRE46873E1 | Multi-targeted RNAi therapeutics for scarless wound healing of skin | General | 1 | Active |
| US8691781B2 | Compositions for treating respiratory viral infections and their use | Chemistry; Metallurgy | 1 | Active |
| US9868952B2 | Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza | Chemistry; Metallurgy | 0 | Active |
| US7781414B2 | Targets for tumor growth inhibition | Physics | 0 | Expired |
| US12054714B2 | Peptide docking vehicle for targeted nucleic acid delivery | Chemistry; Metallurgy | 0 | Active |
| US11697813B2 | Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis | Chemistry; Metallurgy | 0 | Active |
| US12280105B2 | Compositions and methods of mRNA vaccines against novel coronavirus infection | Chemistry; Metallurgy | 0 | Active |
| US9506063B2 | SiRNA compositions and methods for treatment of HPV and other infections | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.